Suppr超能文献

日本发作性睡病量表和瑞士发作性睡病量表对日本 1 型发作性睡病患者筛查的信度和效度。

Reliability and validity of the Japanese version of the Ullanlinna Narcolepsy Scale and Swiss Narcolepsy Scale for screening Japanese individuals with narcolepsy type 1.

机构信息

Department of Somnology, Tokyo Medical University, SY building 5-10-10 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan; Japan Somnology Center, Neuropsychiatric Research Institute, SY building 5-10-10 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan.

Japan Somnology Center, Neuropsychiatric Research Institute, SY building 5-10-10 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan.

出版信息

Sleep Med. 2023 Sep;109:245-251. doi: 10.1016/j.sleep.2023.07.015. Epub 2023 Jul 19.

Abstract

OBJECTIVE

To validate the Japanese versions of the Ullanlinna Narcolepsy Scale (J-UNS) and Swiss Narcolepsy Scale (J-SNS) for screening narcolepsy in the Japanese population and to discuss strategies for their use in hypersomniac individuals.

METHODS

We selected 451 outpatients with excessive daytime sleepiness (EDS) already diagnosed according to the International Classification of Sleep Disorders third edition. They responded to both scales twice at 1-month intervals. After eliminating individuals who met the exclusion criteria, validity and reliability analyses were performed on 408 and 381 participants, respectively.

RESULTS

Patients with narcolepsy type 1 (NT1) displayed higher J-UNS and lower J-SNS scores than those with NT2 and other sleep disorders. The intraclass correlation coefficients and weighted κ coefficient for scale scores in the total participants and patients with NT1 were ≥0.70 and ≥ 0.40, respectively, indicating high reliability. Furthermore, both the sensitivity and specificity of these scales upon using the original cut-off scores (14 for UNS and 0 for SNS) for detecting NT1 were 0.70 or ≥0.70, suggesting high validity. Additionally, the receiver operating characteristic curve analysis revealed that the best cut-off score did not change for the J-SNS but that for the J-UNS, it increased to 18. In our study, the scale's sensitivity and specificity changed from 96% to 82% and 58%-78%, respectively.

CONCLUSIONS

Both scales revealed satisfactory screening abilities for NT1 in the Japanese population. However, it may be better to use J-UNS cut-off scores of 18 for a population with EDS.

摘要

目的

验证日本发作性睡病严重度量表(J-UNS)和瑞士发作性睡病量表(J-SNS)在日本人群中筛查发作性睡病的有效性,并讨论在嗜睡人群中使用这些量表的策略。

方法

我们选择了 451 名已根据国际睡眠障碍分类第三版诊断为日间过度嗜睡(EDS)的门诊患者。他们在 1 个月的间隔内两次回答这两个量表。在排除符合排除标准的个体后,分别对 408 名和 381 名参与者进行了有效性和可靠性分析。

结果

1 型发作性睡病(NT1)患者的 J-UNS 评分较高,J-SNS 评分较低,而 2 型和其他睡眠障碍患者则较低。总参与者和 NT1 患者的量表评分的组内相关系数和加权κ系数均≥0.70 和≥0.40,表明具有较高的可靠性。此外,使用原始截断值(UNS 为 14,SNS 为 0)检测 NT1 时,这些量表的灵敏度和特异性均≥0.70,表明具有较高的有效性。此外,受试者工作特征曲线分析显示,J-SNS 的最佳截断值没有变化,而 J-UNS 的截断值增加到 18。在我们的研究中,量表的灵敏度和特异性从 96%变为 82%和 58%-78%。

结论

两种量表均显示出在日本人群中对 NT1 具有令人满意的筛查能力。然而,对于 EDS 人群,使用 J-UNS 的截断值 18 可能更好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验